Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central anxious technique, conolidine modulates alternate molecular targets. A Science Innovations research located that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://johna801vlb4.wikievia.com/user